ARCHIVES

New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Definitions, New Categories Of Centers Suggested By Cantril

July 2, 1976

House Committee Seeks Information on ImClone Insider Stock Trading.

March 29, 2002

Six Grants Awarded, Five More On Way For Elderly Research

May 4, 1984

NIH Proposes Stricter Rules On Extramural Research Financial Conflicts

May 21, 2010

DCBDC Board OK’s Concepts For New Small Grant Programs

March 23, 1990

Includes June issue of Business & Regulatory Report.

June 28, 2002